Symbiotec Arm Signs Exclusive US Deal For Two DCV Injectables

30 September 2026

Symbiotec Pharmalab Ltd.

No recent updates to show.

Recent Events

Symbiotec Pharmalab Recreates Promoter Pledges Covering 12.82% Of Share Capital

Symbiotec Pharmalab Discloses 5.44% Promoter Share Pledge To Beacon Trusteeship

Symbiotec Pharmalab Sees Mirae Asset Mutual Fund Acquire 5.44% Stake

Get features of